Skip to main content
SpringerLink
Log in

Brca2 hereditary breast cancer pathophenotype

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Four BRCA2 hereditary breast cancer (HBC) families manifested significant excesses of ‘tubular-lobular group’ (TLG) invasive carcinomas and lobular carcinoma in situ/atypical lobular hyperplasia in comparison to BRCA1-HBC cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77: 697-709, 1996

    PubMed  Google Scholar 

  2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Magnion J, Collins N, Gregory S, Gumbs C, Michlem G, Tarfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DP, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792, 1995

    PubMed  Google Scholar 

  3. Fisher ER, Gregorio RM, Redmond C, Fisher B: Tubulolobular invasive breast cancer: A variant of lobular invasive cancer. Human Pathol 8: 679-683, 1977

    Google Scholar 

  4. Stalsberg H, Thomas DB, Noonan EA: The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Int J Cancer 44: 399-409, 1989

    PubMed  Google Scholar 

  5. Marcus JN, Watson P, Page DL, Lynch HT: The pathology and heredity of breast cancer in younger women. J Natl Cancer Inst (Monogr) 16: 23-34, 1994

    Google Scholar 

  6. Borg Å, Zhang Q-X, Johannsson O, Olsson H: High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas. J Natl Cancer Inst 86: 792-794, 1994

    PubMed  Google Scholar 

  7. McDivitt RW, Hutter RVP, Foote FW, Stewart FW: In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA 201: 96-100, 1967

    PubMed  Google Scholar 

  8. Haagensen CD, Lane N, Lattes R, Bodian C: Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42: 737-769, 1978

    PubMed  Google Scholar 

  9. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW: Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Human Pathol 22: 1232-1239, 1991

    Google Scholar 

  10. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW: Infiltrating lobular carcinoma of the breast. Histopathol 6: 149-161, 1982

    Google Scholar 

  11. Narod SA, Ford D, Devilee P, Barkadottir RB, Lynch HT, Smith SA et al.: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56: 254-264, 1995

    PubMed  Google Scholar 

  12. Lynch H, Marcus JN, Watson P, Page D: Distinctive clinicopathologic features of BRCA1-linked hereditary breast cancer. Proc Am Soc Clin Oncol 13: 56, 1994

    Google Scholar 

  13. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jaquemier J, Birnbaum D, Sobol H: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471-474, 1996

    PubMed  Google Scholar 

  14. Sigurdsson H, Agnarsson BA, Jonasson JG, Bjornsdottir IB, Barkardottir RB, Gudlaugsdottir S, Egilsson V: Worse survival among breast cancer patients in families carrying the BRCA2 susceptibility gene. Breast Cancer Res Treat 37(Suppl): 33, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, St. Luke's Hospital, Chesterfield, MO

    Joseph N. Marcus

  2. Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha

    Patrice Watson & Henry T. Lynch

  3. Department of Pathology, Vanderbilt University School of Medicine, Nashville, USA

    David L. Page

  4. Women's College Hospital, Toronto, Ontario, Canada

    Steven A. Narod

  5. Department of Medicine, McGill University, Montreal, Quebec, Canada

    Patricia Tonin

  6. International Agency for Research on Cancer, Lyon, France

    Gilbert M. Lenoir & Olga Serova

Authors
  1. Joseph N. Marcus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrice Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David L. Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven A. Narod
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patricia Tonin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gilbert M. Lenoir
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olga Serova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Henry T. Lynch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marcus, J.N., Watson, P., Page, D.L. et al. Brca2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44, 275–277 (1997). https://doi.org/10.1023/A:1005830230664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005830230664

Search

Navigation